Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

In this column, the author discusses how food biotechnology is evolving from scientific innovation into a scalable manufacturing platform capable of reshaping the future of food production through ...

R&D investment, CRISPR, NGS, personalized medicine and diagnostics drive demand, while strategic partnerships accelerate reagent innovation and commercialization.Dublin, Nov. 02, 2026 (GLOBE NEWSWIRE) ...

Vir Biotechnology (VIR) has signed a collaboration and license agreement with Gilead focused on three PRO-XTEN dual-masked ...

Designed to provide broad exposure to the Health Care ETFs category of the market, the iShares Biotechnology ETF (IBB) is a smart beta exchange traded fund launched on 02/05/2001. What Are Smart Beta ...

The average one-year price target for Puma Biotechnology (NASDAQGS:PBYI) has been revised to $6.12 / share. This is an increase of 20.00% from the prior estimate of $5.10 dated August 1, 2026. These ...

Vir Biotechnology is approaching multiple clinical readouts from drugs with positive data previously. Click here to read an ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

The Treasury Department’s proposed restrictions on U.S. investment in Chinese biopharma collide with Beijing’s new export ...

Following a 50.2% increase in NAV during the year, the trust expects total dividends payable for the financial year ending August 31, 2027, to increase by the same percentage, in line with its ...

The National Security Commission on Emerging Biotechnology visited UW–Madison to discuss Wisconsin’s biohealth strengths, ...

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform ...